skip to main content

We are updating our website to add some new features. Scheduled maintenance is planned for Monday 20th July and during this time the website will be unavailable. Please save any forms you are completing in advance of this.

Back

John Cassidy

  • Name:
    John Cassidy
  • Job Title:
    Kindred Capital

Profile

John is an entrepreneur with dual expertise in cancer biology and financial economics. He has over 10 years’ experience in drug development; spanning academia (University of Cambridge), industry (MedImmune) and start-ups. John is founder, and currently serves as Executive Chairman, of CCG.ai, a Y Combinator backed start-up bring­­­­ing AI to precision oncology. He holds a Masters in Pharmacology (1st Class; top UK graduate) from the University of Glasgow, a PhD in Functional Genomics from the University of Cambridge, and has recently completed an MBA focussed on health economics. In 2018 John was honoured on the Forbes 30 Under 30 (Europe) list for his contributions to biotechnology and in 2020 became the youngest Fellow of the Royal Society of Biology (FRSB).